Establishment of a rat model of chronic heart failure by transverse aortic constriction and observation of its pathological process
Author:
  • Article
  • | |
  • Metrics
  • |
  • Reference [12]
  • | |
  • Cited by
  • | |
  • Comments
    Abstract:

    Objective To observe the pathological changes of heart failure caused by transverse aortic constriction in rats. Methods Partial thoracotomy was performed to the second rib and the transverse aortic constriction was performed between the innominate and left carotid arteries to establish a model of heart failure in 24 rats. The same operation was performed on another 8 rats, except for the ligation of the transverse aorta. Echocardiographic assessment, hemodynamic measurement, myocardial histopathological examination and NT-proBNP measurement were performed to the sham group at 12 weeks and model group at 4 weeks, 8 weeks, 12 weeks after the operation. Result At 4 weeks after the operation, NT-proBNP, EF, FS and -dp/dtmax of the model group was significantly increased and LVESV, +dp/dtmax of the model group were significantly decreased (P<0.05). At 8 weeks after the operation, EF and-dp/dtmax of the model group were increased and +dp/dtmax of the model group was significantly decreased (P<0.05). At 12 weeks after the operation, NT-proBNP, EF and +dp/dtmax of the model group were decreased, and LVESV, LVEDV and -dp/dtmax of the model group were increased (P<0.05). The cardiomyocytes became hypertrophic and lined up in disorder at 4 weeks after the operation. Pathologic examination of the myocardial tissue showed connective tissue proliferation and inflammatory cell infiltration at 8 weeks after the operation, and cardiomyocyte apoptosis and collagen fiber deposition at 12 weeks after the operation. Conclusions Transverse aortic constriction induces heart failure in rats. The pathological processes are compensatory hypertrophy at 4 weeks after the operation, initial reaction of decompensation at 8 weeks after the operation, and heart failure at 12 weeks after the operation.

    Reference
    [1] Kim TT, Dyck JR. Is AMPK the savior of the failing heart?[J]. Trends Endocrinol Metab, 2015, 26(1):40-48.
    [2] 刘宝辉, 李明凯, 罗晓星, 等. 心力衰竭实验动物模型构建方法研究[J]. 中国心血管杂志, 2013, 18(3):233-236.
    [3] 芦玲巧, 曾翔俊, 郝刚. 大鼠心力衰竭模型的构建与鉴定[J]. 中国比较医学杂志, 2012, 22(8):22-25.
    [4] 焦宏, 王晓玲, 陈彦静, 等. 参麦注射液对肥厚心肌大鼠左心室乳头肌电活动的影响[J]. 中国中药杂志, 2014, 39(15):2956-2959.
    [5] deAlmeida AC, van Oort RJ, Wehrens XH. Transverse aortic constriction in mice[J]. J Vis Exp, 2010, 38:1729.
    [6] 廉洪建, 冯玄超, 啜文静, 等. 创伤较小的小鼠主动脉弓缩窄术的建立[J]. 中国比较医学杂志, 2015, 25(2):42-45.
    [7] Hall C. NT-ProBNP:the mechanism behind the marker[J]. J Cardiac Fail, 2005, 11(5):81-83.
    [8] Grewal J, McKelvie R, Lonn E, et al. BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction[J]. Eur J Heart Fail, 2008, 10(3):252-259.
    [9] McDonagh TA, Holmer S, Raymond I, et al. NT-proBNP and the diagnosis of heart failure:a pooled analysis of three European epidemiological studies[J]. Eur J Heart Fail, 2004, 6(3):269-273.
    [10] Gajarsa JJ, Kloner RA. Left ventricular remodeling in the post-infarction heart:a review of cellular, molecular mechanisms, and therapeutic modalities[J]. Heart Failure Rev, 2011, 16(1):13-21.
    [11] Wollert KC, Drexler H. Regulation of cardiac remodeling by nitric oxide:focus on cardiac myocyte hypertrophy and apoptosis[J]. Heart Fail Rev, 2002, 7(4):317-325.
    [12] Liu L, Wang C, Sun D, et al. Calhex231 ameliorates cardiac hypertrophy by inhibiting cellular autophagy in vivo and in vitro[J]. Cell Physiol Biochem, 2015, 36(4):1597-1612.
    Related
    Cited by
Get Citation
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Revised:January 12,2016
  • Online: April 28,2016
Article QR Code